29 results
FWP
ACXP
Acurx Pharmaceuticals, Inc.
2 Apr 24
Free writing prospectus
7:31am
for C. difficile infection (CDI) ACX - 375 targets all known gram - positive bacterial infections (MRSA, VRE, PRSP) Phase 3 Ready Successful Phase 1 … Pseudomonas aeruginosa and CR Enterobacteriaceae infections combined 2 Second DNA Pol IIIC Inhibitor ACX - 375C Oral and I.V. formulation targets
424B5
ggustryrm6
15 Nov 23
Prospectus supplement for primary offering
4:49pm
424B3
rcunex 26hv8fcb8
13 Jul 23
Prospectus supplement
4:32pm
424B5
81p4t kaw9k
17 May 23
Prospectus supplement for primary offering
4:25pm
424B3
8pvye pkx
23 Sep 22
Prospectus supplement
8:19am
424B5
ttz65 nd467xo
25 Jul 22
Prospectus supplement for primary offering
4:26pm
S-3
46a0lg
1 Jul 22
Shelf registration
8:46am